ClinicalTrials.Veeva

Menu
C

Chatham County Health Department | Clinical Trials Unit

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Emtricitabine
Tenofovir Alafenamide
TAF
Rilpivirine
Lenacapavir
FTC
Bictegravir
Islatravir
Tenofovir Disoproxil Fumarate
TDF

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 17 total trials

Dose Ranging, Switch Study of Islatravir (ISL) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]

This is a randomized, controlled, double-blind, study to evaluate the safety and tolerability of islatravir (ISL) + ulonivirine based on review of th...

Active, not recruiting
HIV-1 Infection
Drug: Islatravir
Drug: Placebo to Ulonivirine

The primary objective of this study is to evaluate the efficacy of oral weekly islatravir (ISL) in combination with lenacapavir (LEN) in virologicall...

Active, not recruiting
HIV-1 Infection
Drug: B/F/TAF
Drug: ISL

The primary objective of this study is to evaluate the antiviral activity of lenacapavir (formerly GS-6207) administered as an add-on to a failing re...

Active, not recruiting
HIV-1-infection
Drug: Optimized Background Regimen (OBR)
Drug: Failing ARV Regimen

Trial sponsors

Gilead Sciences logo
Janssen (J&J Innovative Medicine) logo
ViiV Healthcare logo
Merck Sharp & Dohme (MSD) logo
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems